SEC Form 4/A · accession 0001477384-26-000009
First Tracks Biotherapeutics, Inc. · TRAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John A Orwin
Director
Period of report
May 12, 2026
Accepted (ET)
Jun 12, 2026 · 4:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002091349
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | May 12, 2026 | A | 2,500 | A | — | — | Common Stock | 2,500 | 2,500 | D |
| Stock Option (right to buy)F3 | $17.81 | May 12, 2026 | A | 7,000 | A | — | May 11, 2036 | Common Stock | 7,000 | 7,000 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F3The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Remarks
This amended Form 4, as originally filed on May 14, 2026, is being filed to correct the amount of stock options and RSUs granted to the Reporting Person. This Form 4 amendment updates both equity awards to reflect 7,000 stock options and 2,500 RSUs originally granted to the Reporting Person on May 12, 2026.